labiotech.eu rank 294 |
Number of domains linking to labiotech.eu 2 | semantic flow 0.16 |
Number of links to labiotech.eu 2 | semantic flow 0.16 |
Number of domains linked from labiotech.eu 31 | semantic flow 2.92 |
Number of links from labiotech.eu 39 | semantic flow 2.92 |
Pages with highest topical PageRank pointing to domain.
url / atext / target url | |
---|---|
https://labiotech.eu/hiv-cure-crouzet-innavirvax/ switzerland ↳https://labiotech.eu/tag/switzerland/ | |
https://labiotech.eu/hiv-cure-crouzet-innavirvax/ next post boehringer buys a 210m ticket to virus based immuno oncology ↳https://labiotech.eu/boehringer-e210m-virus-immuno-oncology/ | |
https://labiotech.eu/tag/lung-cancer/ astrazeneca s cancer treatment gets breakthrough therapy designation ↳https://labiotech.eu/astrazeneca-cancer-breakthrough-therapy/ | |
https://labiotech.eu/tag/switzerland/ what exactly happens in the cells of people with down s syndrome ↳https://labiotech.eu/downs-syndrome-cause-switzlerland/ |
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Interview: This Biotech could have the first HIV Cure on the Market https://labiotech.eu/hiv-cure-crouzet-innavirvax/ | 0.28 | 1 | 40 | 11 | 1 | 1 | 0 | 0 | |
GSK is advancing a revolutionary Dual HIV Therapy https://labiotech.eu/gsk-dual-therapy-hiv-cure-dolutegravir/ | 0.28 | 1 | 41 | 10 | 1 | 1 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://hivplusmag.com/ | 1 | 0.08 | hivplusmag.com |
http://positivelypositive.ca/ | 1 | 0.07 | positivelypositive.ca |
Relevant domains with most links from selected domain.
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://labiotech.eu/hiv-cure-abivax-results/ | 1 | 0.15 | 0.98 | 0.08 | 1 | yes | 42 | 12 | 2 | 1 | 1 | 1 | |
https://labiotech.eu/tag/abivax/ | 1 | 0.16 | 0.97 | 0.07 | 1 | yes | 28 | 8 | 0 | 0 | 0 | 0 | |
https://labiotech.eu/abivax-interview-antiviral-hiv-hepatitis/ | 1 | 0.16 | 0.97 | 0.07 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://labiotech.eu/viiv-healthcare-hiv-treatment/ | 1 | 0.16 | 0.98 | 0.07 | 1 | yes | 39 | 12 | 1 | 1 | 0 | 0 | |
https://labiotech.eu/from-the-clinic/ | 1 | 0.16 | 0.97 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://labiotech.eu/hiv-cure-antibody-sanofi/ | 1 | 0.16 | 0.97 | 0.07 | 1 | yes | 45 | 14 | 2 | 2 | 0 | 0 | |
https://labiotech.eu/tag/france/ | 1 | 0.16 | 0.97 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://labiotech.eu/author/alex/ | 1 | 0.16 | 0.97 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://labiotech.eu/partners/ | 1 | 0.16 | 0.9 | 0.06 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://labiotech.eu/story/ | 1 | 0.16 | 0.71 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://labiotech.eu/immunotherapy-reaches-breakthrough-in-eliminating-hiv/ | 12 | 0.16 | 0.98 | 0.92 | 1 | yes | 51 | 20 | 6 | 4 | 0 | 0 | |
https://labiotech.eu/hiv-vaccine-sanofi-gsk-nih-gates/ | 12 | 0.15 | 0.98 | 0.87 | 1 | yes | 47 | 20 | 3 | 2 | 1 | 1 | |
https://labiotech.eu/hiv-cure-abivax-results/ | 12 | 0.15 | 0.98 | 0.76 | 1 | yes | 42 | 12 | 2 | 1 | 1 | 1 | |
https://labiotech.eu/hiv-cure-bionor-vaccine-celgene/ | 8 | 0.16 | 0.98 | 0.54 | 1 | yes | 47 | 18 | 6 | 6 | 0 | 0 | |
https://labiotech.eu/tag/hiv/ | 7 | 0.16 | 0.98 | 0.53 | 1 | yes | 28 | 13 | 0 | 0 | 0 | 0 | |
https://labiotech.eu/hiv-cure-antibody-sanofi/ | 4 | 0.16 | 0.97 | 0.3 | 1 | yes | 45 | 14 | 2 | 2 | 0 | 0 | |
https://labiotech.eu/tag/abivax/ | 4 | 0.16 | 0.97 | 0.29 | 1 | yes | 28 | 8 | 0 | 0 | 0 | 0 | |
https://labiotech.eu/viiv-healthcare-hiv-treatment/ | 3 | 0.16 | 0.98 | 0.21 | 1 | yes | 39 | 12 | 1 | 1 | 0 | 0 | |
https://labiotech.eu/tag/nih/ | 2 | 0.16 | 0.96 | 0.07 | 0.85 | yes | 22 | 5 | 0 | 0 | 0 | 0 | |
https://labiotech.eu/from-the-clinic/ | 1 | 0.16 | 0.97 | 0 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.